Psilocybin acts as a partial agonist at 5-HT2A serotonin receptors, modulating neurotransmitter signaling and potentially interrupting the aberrant neural pathways associated with cluster headaches. In cluster headache treatment, it appears to have a prophylactic effect by reducing headache frequency and intensity, likely through its ability to reset neurological pain circuits and potentially modify inflammatory responses.